Y-Intercept (HK)’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
+31,539
New +$1.19M 0.03% 923
2025
Q3
Sell
-145,941
Closed -$4.4M 1642
2025
Q2
$4.4M Buy
+145,941
New +$4.95M 0.11% 268
2025
Q1
Sell
-8,001
Closed -$434K 1262
2024
Q4
$434K Sell
8,001
-996
-11% -$57.1K 0.03% 795
2024
Q3
$585K Sell
8,997
-14,742
-62% -$947K 0.04% 708
2024
Q2
$1.47M Buy
+23,739
New +$1.65M 0.08% 345

Other funds holding CRI

Y-Intercept (HK)'s CRI Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Carter's (CRI) in Q2 2026: 31,539 shares worth $1.3M. The stake represents 0.03% of the portfolio and ranks #923 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in CRI as recently as Q2 2025.

Y-Intercept (HK) first reported a position in CRI in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.4M in Q2 2025. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Y-Intercept (HK) held 31,539 shares of Carter's worth $1.3M as of Q2 2026.
  • Carter's was a new Y-Intercept (HK) position in Q2 2026.
  • Carter's made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #923 holding.
  • Y-Intercept (HK) first reported a position in Carter's in Q2 2024 and has held it in 5 quarters since.
  • Y-Intercept (HK)'s Carter's position peaked at $4.4M in Q2 2025.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.